Glycemia control and glucose-lowering therapy in patients with type 2 diabetes mellitus and cardiovascular disease (review of multicenter randomized trials)
The use of modern pharmaceuticals and cardiovascular disease (CVD) treatment methods has increased life expectancy and improved the quality of life of both patients with normal carbohydrate metabolism and diabetes mellitus (DM). This study provides a review of the literature on glycaemic control and...
Guardado en:
Autores principales: | Sergey V. Kakorin, Ruben A. Iskandaryan, Ashot M. Mkrtumyan |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/81527a880f0446f399dd85522567b619 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials
por: Sergey V. Kakorin, et al.
Publicado: (2016) -
Metformin-Insulin versus Metformin-Sulfonylurea Combination Therapies in Type 2 Diabetes: A Comparative Study of Glycemic Control and Risk of Cardiovascular Diseases in Addis Ababa, Ethiopia
por: Gebrie D, et al.
Publicado: (2021) -
Heart failure in diabetes: From an increased risk to a treatment target
por: Eberhard Standl
Publicado: (2018) -
Heart failure outcomes in patients with type 2 diabetes mellitus: findings from the cardiovascular outcome trials of antidiabetes agents
por: Stefan D. Anker
Publicado: (2019) -
The level of glycemia as a risk factor of cardiovascular diseases
por: Ashot Musaelovich Mkrtumyan
Publicado: (2010)